EXANE DERIVATIVES - QIAGEN NV ownership

QIAGEN NV's ticker is and the CUSIP is N72482AB3. A total of 2 filers reported holding QIAGEN NV in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of QIAGEN NV
ValueSharesWeighting
Q3 2020$1,466,150,000
-84.4%
4
-87.9%
0.42%
-83.8%
Q1 2020$9,389,226,000
+65.5%
33
+50.0%
2.62%
+149.6%
Q4 2019$5,674,481,000
+488.7%
22
+450.0%
1.05%
+507.5%
Q3 2019$963,869,000
-70.0%
4
-63.6%
0.17%
-69.3%
Q2 2019$3,214,180,000
+22.2%
11
+22.2%
0.56%
+8.3%
Q1 2019$2,630,020,000
+422.2%
9
+350.0%
0.52%
+477.8%
Q4 2018$503,648,00020.09%
Other shareholders
QIAGEN NV shareholders Q4 2020
NameSharesValueWeighting ↓
EXANE DERIVATIVES 4$1,466,150,0000.42%
Zurcher Kantonalbank (Zurich Cantonalbank) 1,800,000$3,239,0000.02%
AMUNDI ASSET MANAGEMENT US, INC. 1,600,000$2,954,0000.00%
BARCLAYS PLC 1,000,000$1,823,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 128,000$236,0000.00%
CREDIT SUISSE AG/ 400,000$738,0000.00%
JPMORGAN CHASE & CO 1,400,000$2,551,0000.00%
View complete list of QIAGEN NV shareholders